Prevalence of CARD15/NOD2 mutations in Caucasian healthy people

被引:113
作者
Hugot, Jean-Pierre
Zaccaria, Isabelle
Cavanaugh, Juleen
Yang, Huiying
Vermeire, Severine
Lappalainen, Maarit
Schreiber, Stefan
Annese, Vito
Jewell, Derek P.
Fowler, Elizabeth V.
Brant, Steven R.
Silverberg, Mark S.
Cho, Judy
Rioux, John D.
Satsangi, Jack
Parkes, Miles
机构
[1] Univ Paris 07, AP HP, Hop Robert Debre, INSERM Avenir U763,Serv Gastroenterol Pediat, F-75019 Paris, France
[2] Univ Paris 07, AP HP, Hop Robert Debre, INSERM CIE 5,Unit Clin Epidemiol, F-75019 Paris, France
[3] Australian Natl Univ, Sch Med, Med Genet Res Unit, Canberra, ACT 2600, Australia
[4] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90024 USA
[5] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium
[6] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland
[7] Univ Helsinki, Biomed Helsinki, FIN-00014 Helsinki, Finland
[8] Univ Kiel, Inst Clin Mol Biol, D-2300 Kiel, Germany
[9] Osped CSS IRCCS, UO Gastroenterol, Dipartimento Med Gen & Specialist, San Giovanni Rotondo, Italy
[10] Radcliffe Infirm, Gastroenterol Unit, Oxford, England
[11] Royal Brisbane & Womens Hosp, Res Fdn Clin Res Ctr, Chrohns & Colitis Lab, Queensland Inst Med Res, Brisbane, Qld, Australia
[12] Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21218 USA
[13] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA
[14] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Dept Med, Toronto, ON M4X 1K9, Canada
[15] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Dept Surg, Toronto, ON M4X 1K9, Canada
[16] Univ Chicago Hosp, Dept Med, Martin Boyer Genet Res Labs, Gastroenterol Sect, Chicago, IL 60637 USA
[17] Univ Montreal, Montreal, PQ H2X 3J4, Canada
[18] Inst Cardiol Montreal, Montreal, PQ H2X 3J4, Canada
[19] MIT, Broad Inst, Cambridge, MA 02139 USA
[20] Harvard Univ, Cambridge, MA 02138 USA
[21] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Edinburgh EH8 9YL, Midlothian, Scotland
[22] Addenbrookes Hosp, Gastroenterol Unit, Cambridge CB2 2QB, England
关键词
D O I
10.1111/j.1572-0241.2007.01149.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Crohn's disease (CD) has been associated with CARD15/NOD2 mutations in Caucasians. The R702W, G908R, and 1007fs mutations represent 82% of the mutated chromosomes. The relative risk of developing CD in homozygous or compound heterozygous people has been estimated as between 10 and 40 times that of the general population. This high risk may support the opinion that CARD15/NOD2 variants are strong CD risk factors at the individual and population levels. SUBJECTS AND METHODS: The allele and genotype frequencies were calculated for the R702W, G908R, and 1007fs mutations in 3,575 Caucasian healthy controls recruited by 15 groups distributed on three continents. Geographic homogeneity was tested and the observed proportion of double mutants was compared with the expected value using chi(2) tests. RESULTS: The allele frequencies of the R702W, G908R, and 1007fs mutations were 4.3% (3.6-4.9), 1.2% (0.8-1.6), and 2.3% (1.8-2.8), respectively, with large geographic fluctuations of the G908R, 1007fs, and wild-type alleles (P < 0.0001). At the population level, no simple relationship was observed between mutation frequencies and the disease incidences in the studied populations. At the individual level, no significant deficit of double-dose mutation carriers among healthy controls was found, providing strong evidence that the penetrances of the most at-risk genotypes are low. CONCLUSION: Altogether, these data confirm that CARD15/NOD2 acts in interaction with other unknown risk cofactors.
引用
收藏
页码:1259 / 1267
页数:9
相关论文
共 77 条
[1]   Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility [J].
Addo, A ;
Le, J ;
Li, W ;
Aksentijevich, I ;
Balow, J ;
Lee, A ;
Gregersen, PK ;
Kastner, DL ;
Remmers, EF .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (03) :198-203
[2]  
Ahmad T, 2003, GASTROENTEROLOGY, V125, P281
[3]   Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy -: An Italian Group for Inflammatory Bowel Disease Study [J].
Annese, V ;
Palmieri, O ;
Latiano, A ;
Ardizzone, S ;
Castiglione, F ;
Cottone, M ;
D'Incà, R ;
Gionchetti, P ;
Papi, C ;
Riegler, G ;
Vecchi, M ;
Andriulli, A .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (02) :121-124
[4]   Crohn's disease in the Hunter Valley region of Australia [J].
Anseline, PF .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1995, 65 (08) :564-569
[5]   NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? [J].
Arnott, IDR ;
Nimmo, ER ;
Drummond, HE ;
Fennell, J ;
Smith, BRK ;
MacKinlay, E ;
Morecroft, J ;
Anderson, N ;
Kelleher, D ;
O'Sullivan, M ;
McManus, R ;
Satsangi, J .
GENES AND IMMUNITY, 2004, 5 (05) :417-425
[6]   Association of NOD2 with Crohn's disease in a homogenous Irish population [J].
Bairead, E ;
Harmon, DL ;
Curtis, AM ;
Kelly, Y ;
O'Leary, C ;
Gardner, M ;
Leahy, DT ;
Vaughan, P ;
Keegan, D ;
O'Morain, C ;
O'Donoghue, D ;
Shanahan, F ;
Parfrey, NA ;
Quane, KA .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (03) :237-244
[7]   Genetics and the population history of Europe [J].
Barbujani, G ;
Bertorelle, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :22-25
[8]  
Bonen DK, 2002, GASTROENTEROLOGY, V122, pA29
[9]   Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes [J].
Brant, SR ;
Picco, MF ;
Achkar, JP ;
Bayless, TM ;
Kane, SV ;
Brzezinski, A ;
Nouvet, FJ ;
Bonen, D ;
Karban, A ;
Dassopoulos, T ;
Karaliukas, R ;
Beaty, TH ;
Hanauer, SB ;
Duerr, RH ;
Cho, JH .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (05) :281-289
[10]   Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation [J].
Büning, C ;
Genschel, J ;
Bühner, S ;
Krüger, S ;
Kling, K ;
Dignass, A ;
Baier, P ;
Bochow, B ;
Ockenga, J ;
Schmidt, HHJ ;
Lochs, H .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) :1073-1078